Skip to main content
Equibles
CAI logo

CAI · Caris Life Sciences, Inc. · Webcasts, Transcripts & Audio

Track CAI — free

Use CAI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CAI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$27.54 -2.85 (-9.38%) At close · Oct 6
Russell 1000 member Rebalance outlook locked
Market Cap
$8.92B
Shares
282.60M
Volume · Oct 6 4.75M Avg daily vol (3M) 4.84M

Caris Life Sciences, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Caris Life Sciences, Inc. (CAI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲81.3% $181.40M −$71.79M '25 Q2 25-08-12 ▲113.4% $216.83M $24.32M '25 Q3 25-11-05 · $292.89M $81.96M '25 Q4 26-02-26 ▲78.8% $216.17M −$510,000 '26 Q1 26-05-07 LATEST ▲45.4% $263.71M −$637,000 '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript
Confident tone Record clinical volume and case growth Reimbursement and coverage Financial performance and profitability
Revenue
$263.71M
▲ 45.4% YoY
Diluted EPS
$0.00
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Caris Life Sciences, Inc. (CAI) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Caris Life Sciences, Inc. (CAI) Q1 2026 Earnings Call Transcript
Confident tone New product launches MRD pipeline MCED early detection and Everlywell partnership
Revenue
$216.17M
▲ 78.8% YoY
Diluted EPS
$0.00
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
Confident tone Caris Detect / MCED Profitability and cash flow MI Cancer Seek launch and ASP
Revenue
$292.89M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Caris Life Sciences, Inc. (CAI) Q3 2025 Earnings Call Transcript
Confident tone Whole Exome and Whole Transcriptome platform MRD and monitoring pipeline Revenue growth and case volumes
Revenue
$216.83M
▲ 113.4% YoY
Diluted EPS
$0.08
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Caris Life Sciences, Inc. (CAI) Q2 2025 Earnings Call
Revenue
$181.40M
▲ 81.3% YoY
Diluted EPS
$-7.97
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 webcasts
Key facts CIK 2019410 CUSIP 142152107 13F (30d) 7 filings 7 filers Visit website Investor relations